Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials

Morgan K. Moroi, Mohammed Ruzieh, Nader M. Aboujamous, Mehrdad Ghahramani, Gerald V. Naccarelli, John Mandrola, Andrew J. Foy

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article “Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo”, which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose.

Original languageEnglish (US)
Article number104835
JournalData in Brief
Volume28
DOIs
StatePublished - Feb 2020

All Science Journal Classification (ASJC) codes

  • General

Fingerprint Dive into the research topics of 'Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials'. Together they form a unique fingerprint.

  • Cite this